ÂÜÀòÂÒÂ×

Franzpeter Bracht serves as the Geschäftsführer at Lindis Blood Care GmbH since July 2018. Prior to this role, Franzpeter was the COO/CBO of Glycotope GmbH from June 2007 to November 2017, where significant growth was achieved, expanding the team from 13 to over 220 employees and securing a financing round of €90 million. Franzpeter co-founded NexiGen in 2006 and held the CEO position at Aplagen GmbH from October 2001 to July 2006. Additionally, from 1996 to 2001, Franzpeter worked at Kienbaum Management Consultants GmbH as Principal and Department Head, managing various strategic consulting projects. Educationally, Franzpeter obtained a PhD and Dr. rer. nat. in general Biology, as well as a Diplom in Molecular Biophysics from the University of Düsseldorf between 1991 and 1995.